XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.34

-2.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	10/26/2006 10:49:45 AM
	of 17367

zacks... bull of the day... Buy XOMA Up to $4 Posted Wed Oct 25, 04:19 pm ET by Jason Napodano, CFA Xoma, Ltd. (XOMA) is a biopharmaceutical company that develops products to treat infectious diseases, immunological and inflammatory disorders, and cancer. The company receives royalties on worldwide sales of psoriasis drug Raptiva, as well as provides contract manufacturing and licensing services related to its bacterial cell expression and human engineering technology. Xoma also possesses an interesting early-stage pipeline and collaborative research efforts. We look forward to several positive catalysts the remainder of 2006 to help drive the shares higher. We see fair value at $4.00.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next